CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test
Introduction
The CIITA gene is responsible for encoding a protein called class II transactivator, which plays a crucial role in the immune system. Mutations in the CIITA gene can lead to a rare genetic disorder known as Bare Lymphocyte Syndrome, Type 2, Complementation Group A.
Test Details
The CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test is performed using Next-Generation Sequencing (NGS) technology. NGS Genetic Test refers to the use of this technology to analyze and identify genetic variations in the CIITA gene.
Components and Price
The test costs AED 4400.0 and requires a sample of either blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results are usually delivered within 3 to 4 weeks.
Test Type
The CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A Genetic Test falls under the category of Osteology Dermatology Immunology Disorders.
Doctor and Test Department
The test is conducted by a Dermatologist and falls under the Genetics department.
Pre Test Information
Prior to the test, a clinical history of the patient is taken, especially if they are going for CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A NGS Genetic DNA Test. A Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with CIITA Gene Bare Lymphocyte Syndrome Type 2 Complementation Group A.
Purpose of the Test
The purpose of performing an NGS Genetic Test for CIITA gene mutations is to diagnose Bare Lymphocyte Syndrome, Type 2, Complementation Group A. By identifying specific genetic variations in the CIITA gene, healthcare professionals can confirm the presence of this rare disorder in an individual. This genetic test can help in providing an accurate diagnosis, guiding appropriate treatment options, and predicting the prognosis of the affected individual. It can also assist in genetic counseling and family planning for individuals with a family history of Bare Lymphocyte Syndrome, Type 2, Complementation Group A.
| Test Name | CIITA Gene Bare lymphocyte syndrome type 2 complementation group A Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic DNA Test gene CIITA |
| Test Details |
The CIITA gene is responsible for encoding a protein called class II transactivator, which plays a crucial role in the immune system. Mutations in the CIITA gene can lead to a rare genetic disorder known as Bare Lymphocyte Syndrome, Type 2, Complementation Group A. NGS stands for Next-Generation Sequencing, which is a high-throughput DNA sequencing technology. NGS Genetic Test refers to the use of this technology to analyze and identify genetic variations in the CIITA gene. The purpose of performing an NGS Genetic Test for CIITA gene mutations is to diagnose Bare Lymphocyte Syndrome, Type 2, Complementation Group A. By identifying specific genetic variations in the CIITA gene, healthcare professionals can confirm the presence of this rare disorder in an individual. This genetic test can help in providing an accurate diagnosis, guiding appropriate treatment options, and predicting the prognosis of the affected individual. It can also assist in genetic counseling and family planning for individuals with a family history of Bare Lymphocyte Syndrome, Type 2, Complementation Group A. |
